Rhea-AI Summary
Bioasis Technologies Inc. (OTCQB:BIOAF) has completed a non-brokered private placement, issuing 400,000 common shares at $0.50 each, resulting in gross proceeds of $200,000. The shares will have a four-month hold period in line with securities regulations. Bioasis focuses on developing its proprietary xB3 ™ platform technology to deliver therapeutics across the blood-brain barrier, targeting central nervous system disorders with significant unmet medical needs, including brain cancers and neurodegenerative diseases.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.62%
Tags
FAQ
What is the current stock price of BIOASIS TECHNOLOGIES (BIOAF)?
BIOASIS TECHNOLOGIES (BIOAF) last closed at $0.0001.
What is the market cap of BIOASIS TECHNOLOGIES (BIOAF)?
The market cap of BIOASIS TECHNOLOGIES (BIOAF) is approximately $288.9K.